Inventurus Knowledge Solutions Limited reported its financial results for the quarter and year ended March 31, 2026, showcasing robust growth across key metrics. The company posted a net profit of ₹2,060 million for Q4 FY26, a 39.4% year-on-year increase, while full-year FY26 Profit After Tax (PAT) surged 48.4% to ₹7,216 million. Revenue from operations for the quarter rose 18.5% year-on-year to ₹8,577 million. For the full fiscal year FY26, the company recorded revenue of ₹31,938 million, representing 19.9% growth over FY25. Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published extracts of its audited financial results in "Financial Express" and "Navshakti" on May 15, 2026.

Financial Performance Summary

The company's operational efficiency improved significantly, with Q4 FY26 EBITDA growing 32.7% year-on-year to ₹3,002 million. The EBITDA margin expanded to 35.0% in Q4 FY26 from 31.24% in the corresponding quarter of the previous year. Adjusted PAT for Q4 FY26 stood at ₹2,269 million, up 37.9% YoY. The board noted that the company successfully refinanced its existing term loan during Q3 FY26. The following table presents a consolidated view of the company's financial performance:

The standalone financial results for the quarter and year ended March 31, 2026 were also published. The following table presents key standalone financial metrics:

Regulatory Compliance and Publication

In compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company filed a communication with BSE Limited and the National Stock Exchange of India Limited on May 15, 2026. The communication, signed by Company Secretary and Compliance Officer Sameer Chavan (Membership No. F7211), confirmed the publication of audited financial result extracts in "Financial Express" and "Navshakti" on May 15, 2026. The standalone and consolidated financial results for the quarter and year ended March 31, 2026 were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meeting held on May 13, 2026. The results for the year ended March 31, 2026 were audited by the Statutory Auditors in terms of Regulation 33 of the SEBI LODR Regulations, 2015.

Strategic Acquisition and Board Decisions

In a strategic move to enhance its artificial intelligence capabilities, the board approved the acquisition of 100% of the share capital of Arai Solutions Private Limited for a total cash consideration of INR 11,00,00,000 (Indian Rupees Eleven Crores only). The target entity is engaged in providing consultancy services related to artificial intelligence solutions. Upon completion, Arai Solutions will become a wholly-owned subsidiary of the company. The acquisition is expected to be completed by or before June 20, 2026.

Additionally, the board approved the re-appointment of M/s KKC & Associates LLP as the Internal Auditor for the financial year 2026-27. The board also announced a change in senior management personnel, effective May 14, 2026, wherein Mr. Saransh Mundra will no longer be classified as Senior Management Personnel under SEBI LODR Regulations, though he remains responsible for investor relations.

Operational Metrics

As of March 31, 2026, Inventurus Knowledge Solutions employed 13,331 people, including 1,981 clinically trained staff. The firm serves over 450 enterprise-level customers, with the top 10 clients contributing 37% of total annual revenue. The company accelerated its AI initiatives during the year through key partnerships, including the strategic acquihire of ThinkDTM and the launch of the MyCareHub™ agentic AI platform.

Inventurus Knowledge Solutions Limited's healthcare brand, IKS Health, has completed the acquisition of 100% of the share capital in Arai Solutions Private Limited for a total cash consideration of INR 11,00,00,000 (Indian Rupees Eleven Crores only). The Board of Directors had approved the transaction on May 13, 2026, and pursuant to a Regulation 30(7) update filed with BSE Limited and the National Stock Exchange of India Limited, the acquisition was confirmed as completed on May 14, 2026. With the completion of this transaction, Arai Solutions Private Limited has become a wholly-owned subsidiary of Inventurus Knowledge Solutions Limited.

About the Acquired Entity

Arai Solutions Private Limited (CIN: U58200KA2024PTC187134) is a private limited company incorporated on April 5, 2024, under the laws of India, with its registered office at D-37, Golden Enclave, Airport Road, Vimanapura, Bangalore, Karnataka, 560017, India. The company operates in the Information Technology Enabled Services (ITeS) industry and provides consultancy services related to artificial intelligence solutions across industries, including the healthcare space. Its specific areas of expertise include research and development in algorithms and architectures, deep learning, machine learning, generative AI, large language models, natural language processing, symbolic AI (including knowledge graphs and logic systems), hybrid AI solutions, AI for cybersecurity, and neural networks with hardware acceleration. The acquisition does not constitute a related party transaction, and the Promoter/Promoter Group of Inventurus Knowledge Solutions Limited has no interest in the entity being acquired.

Financial Profile of Arai Solutions

The following table presents the financial details of Arai Solutions Private Limited for FY 2025-26, as disclosed in the regulatory filing:

The revenue history of the target over the last three years is as follows:

Key Acquisition Details

The principal terms of the completed acquisition are summarised below:

Strategic Rationale

IKS Health currently possesses a four-layer healthcare AI stack encompassing EMR integration, platform orchestration, trust/compliance, and AI applications. ARAI's ontology introduces a critical knowledge layer to this existing framework, which the company states makes IKS Health the only full-stack player with proprietary domain intelligence at every level. ARAI's interconnected biomedical knowledge graphs, grounded in peer-reviewed research, feed a central reasoning engine that is directly mappable to IKS Health platform outputs. The acquisition is designed to accelerate the development of a full agentic AI technology stack, with capabilities to create a more efficient proprietary small language model, and is expected to enhance IKS Health's existing care management workflows and accelerate the company's AI R&D.

The following key areas are expected to benefit from accelerated platform development and reduced dependency on third-party AI infrastructure:

• Autonomous coding
• Clinical decisions
• Denial prevention
• Prior authorization reasoning
• Precision medicine

Leadership Perspectives

Sachin K. Gupta, Founder and Global CEO of IKS Health, stated that ARAI's clinical knowledge infrastructure makes IKS Health AI operational models "even more economical, reliable, auditable, and capable of reasoning." He added that uniting ARAI with IKS Health adds a "valuable and complementary layer" to the platform as the company scales its AI-driven and human-in-the-loop approach in line with evolving clinical and regulatory guidelines. Dr. Roland Haas, co-founder and CEO of ARAI, noted that IKS Health is positioned to disrupt the health tech industry by creating AI-driven systems of action, and expressed that ARAI is pleased to join forces as IKS Health extends into next-generation clinical and operational AI models. Dr. Asoke Talukder, co-founder and CAIO of ARAI, highlighted that ARAI's framework fills the critical AI infrastructure knowledge layer, reinforcing IKS Health's position as the only full-stack player with proprietary domain intelligence at every tier.

A key differentiator highlighted in the announcement is ARAI's explainable AI approach, which the company describes as converting "black box AI into glass box AI," enabling predictions that are transparent, explainable, and traceable. IKS Health was founded in 2006 and has been recognised by Black Book as the top provider of AI-driven RCM services, by KLAS for performance and client satisfaction, and by Google Cloud with a DORA Award for "Augmenting Human Expertise with AI."